Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SYNGENE
₹402.55
₹401.20
₹407.10
₹375.25
₹678.95
Markets Today
Historical Performance
As of 24-08-2026 10:41, Syngene International Ltd. share price today is ₹0, with a change of ₹-407.25 (-100.00%) from the previous close of ₹407.25. The stock opened at ₹407.1 and traded between ₹401.2 and ₹407.1, with a total traded volume of 64463 shares. The company has a market capitalization of ₹16019.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹678.95 and ₹375.25, respectively.
Syngene International Ltd. valuation metrics include a P/E ratio of 72.5, EPS of ₹7.87, and book value of ₹3.30. Profitability indicators show ROE of 6.54% along with a dividend yield of 0.3%. Syngene International Ltd. has reported revenue of ₹3600.2 Cr and net profit of ₹221 Cr.
Syngene International Ltd. technical indicators include Day RSI at 40.71, Day MFI at 49.12, Day ADX at 22.23. Additional indicators include Commodity Channel Index (CCI) at -66.2 and Williams %R at -55.63. Momentum indicators show Day MACD at -5.14, Day MACD Signal Line at -5.87, DayATR at 11.27. Rate of Change indicators for Syngene International Ltd. include ROC125 at -8.63 and ROC21 at -3.97.
Exponential moving averages include EMA5 at ₹401.3, EMA10 at ₹402.7, EMA12 at ₹403.2, EMA20 at ₹406, EMA26 at ₹408.4, EMA50 at ₹417.5, EMA100 at ₹437.6, EMA200 at ₹486.2. Simple moving averages include SMA5 at ₹401.3, SMA10 at ₹402.9, SMA20 at ₹404, SMA30 at ₹408.4, SMA50 at ₹421.1, SMA100 at ₹430, SMA150 at ₹443.5, SMA200 at ₹494.1.
Support levels for Syngene Intl are placed at First Support ₹392.97, Second Support ₹389.08, Third Support ₹383.17. Resistance levels are seen at First Resistance ₹402.77, Second Resistance ₹408.68, Third Resistance ₹412.57. Syngene International Ltd. shareholding pattern shows promoter holding at 52.59%, FII holding at 11.82%, DII holding at 0%, public holding at 7.15%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 663 | 960 | 834.40 | 830.10 | 799.30 |
| Operating Expense | 584.60 | 675.70 | 649.70 | 652.60 | 631.20 |
| Operating Profit | 78.40 | 284.30 | 184.70 | 177.50 | 168.10 |
| Depreciation | 95.60 | 95.30 | 97.10 | 100.10 | 94.60 |
| Interest | 4.10 | 6.50 | 6.20 | 7.40 | 5.90 |
| Tax | -7.90 | 48.50 | 13.60 | 18 | 10.20 |
| Net Profit | -2.10 | 148.20 | 16.50 | 66.20 | 74 |
₹402.55
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 52.7 | 52.7 | 52.7 | 52.7 | 52.7 | 52.6 |
| FII | 19.5 | 16.5 | 16.3 | 15 | 13.9 | 11.8 |
| DII | 21.5 | 24.1 | 24.6 | 25.8 | 26.5 | 28 |
| Public | 6 | 6.4 | 6.1 | 6.2 | 6.7 | 7.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 6.84 L | 8.94 L | 76.55% |
| Week | 3.82 L | 5.96 L | 64.09% |
| 1 Month | 8.66 L | 18.04 L | 48.01% |
| 6 Month | 8.03 L | 20.14 L | 39.89% |
Benjamin Graham Value Screen
PEG lower than Industry PEG
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jun, 2026 | 1.25 | FINAL | 26 Jun, 2026 | Equity Share |
| 27 Jun, 2025 | 1.25 | FINAL | 27 Jun, 2025 | Equity Share |
| 28 Jun, 2024 | 1.25 | FINAL | 28 Jun, 2024 | Equity Share |
| 30 Jun, 2023 | 0.5 | FINAL | 30 Jun, 2023 | Equity Share |
| 30 Jun, 2022 | 0.5 | FINAL | 01 Jul, 2022 | Equity Share |
| 30 Jun, 2022 | 0.5 | SPECIAL | 01 Jul, 2022 | Equity Share |
| 16 Jul, 2019 | 0.5 | FINAL | 17 Jul, 2019 | Equity Share |
| 17 Jul, 2018 | 1 | FINAL | 18 Jul, 2018 | Equity Share |
| 20 Jul, 2017 | 1 | FINAL | 21 Jul, 2017 | Equity Share |
| 17 Mar, 2016 | 1 | INTERIM | 19 Mar, 2016 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,148.70 | ₹1,119.25 | ₹823.35 | ₹888.20 | ₹886.40 | ₹2,518.90 |
| % Change | 0.28% | 0.67% | 1.03% | 0.89% | 0.45% | -1.64% |
| Revenue TTM (₹ Cr) | ₹1,479.07 | ₹675.61 | ₹1,682.47 | ₹8,608.30 | ₹3,484.60 | ₹2,287.33 |
| Net Profit TTM (₹ Cr) | ₹199.03 | ₹182.64 | ₹297.32 | ₹352.10 | ₹1,144.30 | ₹665.35 |
| PE TTM | 65.20 | 71.50 | 54.00 | 39.40 | 13.70 | 29.40 |
| 1 Year Return | 99.76 | 95.01 | 91.54 | -19.65 | -1.28 | 20.35 |
| ROCE | 31.54 | 24.22 | 11.36 | 6.81 | 16.26 | 21.95 |
Marksans Pharma Ltd.
₹ 318.25
-0.95%
Orchid Pharma Ltd.
₹ 1001.90
-0.01%
Viyash Scientific Ltd.
₹ 271.00
-1.79%
AstraZeneca Pharma India Ltd.
₹ 7332.00
-1.13%
Bliss GVS Pharma Ltd.
₹ 563.50
-2.69%
Sanofi India Ltd.
₹ 3338.90
-0.41%
Morepen Laboratories Ltd.
₹ 94.78
-1.28%
Procter & Gamble Health Ltd.
₹ 5843.00
+0.25%
Jeena Sikho Lifecare Ltd.
₹ 517.40
+2.38%
Senores Pharmaceuticals Ltd.
₹ 1560.70
+3.13%
OneSource Specialty Pharma Ltd.
₹ 1540.80
+0.38%
Sanofi Consumer Healthcare India Ltd.
₹ 4224.40
+0.05%
Akums Drugs & Pharmaceuticals Ltd.
₹ 763.45
+1.79%
Innova Captab Ltd.
₹ 1077.00
-1.06%
Blue Jet Healthcare Ltd
₹ 604.30
+1.37%
Concord Biotech Ltd.
₹ 1562.40
-0.57%
Aarti Pharmalabs Ltd.
₹ 839.30
+2.75%
Supriya Lifescience Ltd.
₹ 807.65
+0.27%
Alivus Life Sciences Ltd.
₹ 1344.10
-0.50%
Cohance Lifesciences Ltd.
₹ 451.80
-2.42%
Eris Lifesciences Ltd.
₹ 1326.50
-0.13%
Alembic Pharmaceuticals Ltd.
₹ 815.45
-0.77%
Sun Pharma Advanced Research Company Ltd.
₹ 198.94
+1.13%
Strides Pharma Science Ltd.
₹ 991.10
+0.50%
By signing up I certify terms, conditions & privacy policy